TME Modelling & Dose Optimization for Solid Tumor Immunotherapy Development – the TriSalus Translational & Clinical Experience
Time: 1:45 pm
day: Conference Day 1
Details:
- Addressing organ-specific immunosuppressive barriers through strategic MoA selection
- Reflect on the integration of appropriate delivery strategies to enable therapeutic performance
- Analyze the selection of immunologic read-outs for early phase clinical trials to enable detection of biologic activity
